Literature DB >> 16964548

Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis.

Ajay Duseja, Reena Das, Ashim Das, R K Dhiman, Y K Chawla, G Garewal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16964548     DOI： 10.1007/s10620-005-9041-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

2.  Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

Authors:  D K George; S Goldwurm; G A MacDonald; L L Cowley; N I Walker; P J Ward; E C Jazwinska; L W Powell
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

3.  Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

Authors:  S Fargion; M Mattioli; A L Fracanzani; M Sampietro; D Tavazzi; P Fociani; E Taioli; L Valenti; G Fiorelli
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

4.  Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.

Authors:  Ajay Duseja; Reena Das; Mohit Nanda; Ashim Das; Gurjeewan Garewal; Yogesh Chawla
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

5.  HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Authors:  Shivakumar Chitturi; Martin Weltman; Geoffrey C Farrell; David McDonald; James Kench; Christopher Liddle; Dev Samarasinghe; Rita Lin; Shehan Abeygunasekera; Jacob George
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425
  5 in total
  6 in total

1.  Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation.

Authors:  Ajay Duseja; Ashim Das; Radha Krishan Dhiman; Yogesh Kumar Chawla; Reena Das; Sanjay Bhadada; Ravinder Sialy; Kiran Kumar Thumburu; Anil Bhansali; Naveen Kalra
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 2.  Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.

Authors:  Norberto-C Chavez-Tapia; Tonatiuh Barrientos-Gutierrez; Felix-I Tellez-Avila; Francisco Sanchez-Avila; Maria-Antonieta Montano-Reyes; Misael Uribe
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 3.  Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Authors:  Ajay Duseja
Journal:  Indian J Gastroenterol       Date:  2010-12-30

4.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).

Authors:  Ajay Duseja; Naga Chalasani
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

5.  Non-alcoholic Fatty Liver Disease: East Versus West.

Authors:  Swastik Agrawal; Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

6.  Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.

Authors:  Jun-Wei Wang; Chun-Hua Jin; Jiang-Feng Ke; Yi-Lin Ma; Yu-Jie Wang; Jun-Xi Lu; Mei-Fang Li; Lian-Xi Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-05       Impact factor: 6.055
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.